文献速递胸部技术与安全PETCT

PET/CT多病灶影像组学用于肺腺癌无创生存分层与组织学肿瘤风险评估

Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
PubMed 文献 · Eur Radiol · 2022-07-28

本研究回顾性纳入421例初治肺腺癌患者,基于FDG PET/CT影像组学与临床参数构建机器学习模型预测4年生存、3年生存、肿瘤分级及组织学生长模式风险。4年生存模型AUC最高(0.88),其次为3年生存模型(0.84),肿瘤分级与生长模式风险模型AUC均为0.76。模型预测与总生存独立相关。

要点

  • 基于治疗前FDG PET/CT影像组学的机器学习模型可高精度预测肺腺癌长期生存(4年OS模型AUC 0.88)。
  • 肿瘤分级与组织学生长模式风险的预测达到满意精度(AUC均为0.76)。
  • 模型预测的4年与3年生存与总生存独立相关(HR分别为-2.4和-2.36)。

核心结论

  • 机器学习模型能高精度预测肺腺癌患者长期生存结局,并能以满意精度预测组织学分级与主要生长模式风险。

研究设计与样本

  • 回顾性纳入421例组织学证实的初治肺腺癌患者,均有FDG PET/CT影像;分别针对4年OS(n=276)、3年OS(n=280)、肿瘤分级(n=298)和生长模式风险(n=265)四个队列进行分析;勾画FDG高摄取病灶,提取2082个影像组学特征并与端点特异性临床参数结合;构建M4OS、M3OS、MTG、MGPR四种机器学习模型;采用100折蒙特卡洛交叉验证,训练与验证按80:20拆分。

关键影像表现/征象

  • 勾画FDG高摄取病灶后提取2082个影像组学特征,用于构建生存与组织学风险预测模型。

诊断标准与关键数值

  • M4OS预测4年OS的AUC为0.88(95%CI 86.7-88.7)。
  • M3OS预测3年OS的AUC为0.84(95%CI 82.9-84.9)。
  • MTG预测肿瘤分级的AUC为0.76(95%CI 74.4-77.9),MGPR预测生长模式风险的AUC为0.76(95%CI 74.6-78)。
  • M4OS预测与OS独立相关(HR -2.4,95%CI -2.47至-1.64,p<0.05)。
  • M3OS预测与OS独立相关(HR -2.36,95%CI -2.79至-1.93,p<0.05)。

临床应用与阅片要点

  • 原文结论指出机器学习模型能高精度预测肺腺癌长期生存,并可满意预测组织学分级与主要生长模式风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study investigates the ability of machine learning (ML) models trained on clinical data and 2-deoxy-2-[18F]fluoro-D-glucose(FDG) positron emission tomography/computed tomography (PET/CT) radiomics to predict overall survival (OS), tumor grade (TG), and histologic growth pattern risk (GPR) in lung adenocarcinoma (LUAD) patients.

METHODS: A total of 421 treatment-naive patients with histologically-proven LUAD and available FDG PET/CT imaging were retrospectively included. Four cohorts were assessed for predicting 4-year OS (n = 276), 3-year OS (n = 280), TG (n = 298), and GPR (n = 265). FDG-avid lesions were delineated, and 2082 radiomics features were extracted and combined with endpoint-specific clinical parameters. ML models were built for the prediction of 4-year OS (M4OS), 3-year OS (M3OS), tumor grading (MTG), and histologic growth pattern risk (MGPR). A 100-fold Monte Carlo cross-validation with 80:20 training to validation split was employed as a performance evaluation for all models. The association between the M4OS and M3OS predictions with OS was assessed by the Kaplan-Meier survival analysis.

RESULTS: The area under the receiver operator characteristics curve (AUC) was the highest for M4OS (AUC 0.88, 95% confidence interval (CI) 86.7-88.7), followed by M3OS (AUC 0.84, CI 82.9-84.9), while MTG and MGPR performed equally well (AUC 0.76, CI 74.4-77.9, CI 74.6-78, respectively). Predictions of M4OS (hazard ratio (HR) -2.4, CI -2.47 to -1.64, p < 0.05) and M3OS (HR -2.36, CI -2.79 to -1.93, p < 0.05) were independently associated with OS.

CONCLUSION: ML models are able to predict long-term survival outcomes in LUAD patients with high accuracy. Furthermore, histologic grade and predominant growth pattern risk can be predicted with satisfactory accuracy.

KEY POINTS: • Machine learning models trained on pre-therapeutic PET/CT radiomics enable highly accurate long-term survival prediction of patients with lung adenocarcinoma. • Highly accurate survival predictions are achieved in lung adenocarcinoma patients despite heterogenous histologies and treatment regimens. • Radiomic machine learning models are able to predict lung adenocarcinoma tumor grade and histologic growth pattern risk with satisfactory accuracy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhao, Kluge, Papp, et al. Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma. Eur Radiol. 2022. PMID: 35896836. doi:10.1007/s00330-022-08999-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。